Gabapentin and Teveten drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Teveten (eprosartan mesylate). Common drug interactions include contusion among females and intervertebral disc protrusion among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Teveten. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

What is Teveten?

Teveten has active ingredients of eprosartan mesylate. It is often used in high blood pressure. eHealthMe is studying from 1,482 Teveten users. Check the latest studies of Teveten.



On Jul, 15, 2026

15 people who take Gabapentin and Teveten together, and have interactions are studied.

Gabapentin and Teveten drug interactions.

What are the common drug interactions of Gabapentin and Teveten, by gender? *:

female:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Dizziness
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Injection site induration
  7. Joint swelling
  8. Meniscus lesion (lesion of a crescent-shaped piece of cartilage between the femur and the tibia)
  9. Oedema peripheral (superficial swelling)
  10. Dyspepsia (indigestion)

male:

  1. Intervertebral disc protrusion (spinal disc protrusion)
  2. Chronic kidney disease
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Renal failure (kidney dysfunction)

What are the common drug interactions of Gabapentin and Teveten, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Nausea (feeling of having an urge to vomit)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Injection site induration
  5. Joint swelling
  6. Meniscus lesion (lesion of a crescent-shaped piece of cartilage between the femur and the tibia)
  7. Oedema peripheral (superficial swelling)
  8. Chronic kidney disease
  9. Dyspepsia (indigestion)
  10. Dysphagia (a condition in which swallowing is difficult or painful)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 33.33%
  2. Vasomotor Rhinitis (stuffy nose): 4 people, 26.67%
  3. Enlarged Prostate: 4 people, 26.67%
  4. Itching: 4 people, 26.67%
  5. Joint Pain: 4 people, 26.67%
  6. Neck Pain: 4 people, 26.67%
  7. Gastric Disorder (disease of stomach): 4 people, 26.67%
  8. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 3 people, 20.00%
  9. Osteoporosis (bones weak and more likely to break): 3 people, 20.00%
  10. Respiratory Disorder (respiratory disease): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Teveten?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gabapentin and Teveten:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Teveten:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Teveten and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and eprosartan mesylate (the active ingredients of Gabapentin and Teveten, respectively), and Gabapentin and Teveten (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: